Safety, inhibition of platelet aggregation and pharmacokinetics of F(ab′)2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty

Author: Mazurov A.V.   Pevzner D.V.   Antonova O.A.   Byzova T.V.   Khaspekova S.G.   Semenov A.V.   Vlasik T.N.   Samko A.N.   Staroverov I.I.   Ruda M.Ya.  

Publisher: Informa Healthcare

ISSN: 1369-1635

Source: Platelets, Vol.13, Iss.8, 2002-12, pp. : 465-477

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content